Logo

American Heart Association

  2
  0


Final ID: Sa3048

Prevalence and Distribution of Retinal and Deep Learning-Based Versus Actual Coronary Artery Calcium Scores: A Large South Korean Population Aged 21-90 Years

Abstract Body (Do not enter title and authors here): Introduction: Reti-CVD, a novel cardiovascular risk stratification tool derived from deep learning and retinal photography, offers a promising alternative to CT scan-measured Coronary Artery Calcium (CAC) scores in predicting cardiovascular events. This study investigates the profile of Reti-CVD scores using data from three medical centers in South Korea: GC iMED Gangbuk & Gangnam branches and Philip Medical Center.

Hypothesis: Reti-CVD scores can effectively stratify cardiovascular risk across different age groups and genders and correlate with actual CAC scores, demonstrating their utility as predictive markers for cardiovascular risk.

Methods: Data from 598,831 retinal images from Philip Medical Center and 74,859 from GC iMED Gangbuk & Gangnam branches were analyzed for Reti-CVD. The overall dataset consists of 45,858 individuals aged 21-90 years. The distribution of Reti-CVD and CAC scores across various age groups, segmented into ten-year increments, was examined. For 4,685 individuals with available follow-up data, longitudinal changes in Reti-CVD scores over an approximate two-year period were assessed using Pearson’s correlation analysis.

Results: In both Reti-CVD and CAC distributions, each age group exhibited distinct score ranges, with increasing cardiovascular risk as age increased, as shown in Figures 1 and 2. Men had consistently higher scores, indicating gender differences. The longitudinal study further revealed a significant positive correlation between baseline and follow-up Reti-CVD scores (Correlation Coefficient: 0.158, p-value < 2.2e-16).

Discussion: Reti-CVD score analysis in relation to age and gender exhibited similar trends to CAC scores, offering insights into cardiovascular risk profiles and enabling percentile assessments within specific gender and age groups. The correlation between baseline and follow-up scores emphasizes Reti-CVD's potential as a longitudinal cardiovascular risk marker, suggesting the need for closer monitoring and intervention strategies for those with higher initial scores.
  • Cho, Yunnie  ( Seoul National University Hospital , Seoul , Korea (the Republic of) )
  • Tan, Yong Yu  ( Cork University Hospital , Singapore , Singapore )
  • Wong, Tien  ( Singapore National Eye Centre , Singapore , Singapore )
  • Cheng, Ching-yu  ( Singapore National Eye Centre , Singapore , Singapore )
  • Generoso, Giuliano  ( University Hospital , Sao Paulo , Brazil )
  • Correa Fabiano, Ronaldo  ( Uni of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Bensenor, Isabela  ( HOSPITAL UNIVERSITARIO , Sao Paulo , Brazil )
  • Bittencourt, Marcio  ( UPMC , Pittsburgh , Pennsylvania , United States )
  • Cho, Jun Hwan  ( Chung-Ang University Gwangmyeong Hospital , Gwangmyeong , Korea (the Republic of) )
  • Rim, Tyler  ( MediWhale Inc. , Singapore , Singapore )
  • Choi, Beom-hee  ( GC-iMED , Seoul , Korea (the Republic of) )
  • Jung, Gyouchul  ( GC-iMED , Seoul , Korea (the Republic of) )
  • Lee, Chan Joo  ( Severance Cardiovascular Hospital , Seoul , Korea (the Republic of) )
  • Park, Sung Ha  ( Severance Cardiovascular Hospital , Seoul , Korea (the Republic of) )
  • Kim, Hyeonmin  ( Mediwhale Inc. , Seoul , Korea (the Republic of) )
  • Seo, Chanyang  ( MediWhale Inc. , Singapore , Singapore )
  • Thakur, Sahil  ( Singapore National Eye Centre , Singapore , Singapore )
  • Author Disclosures:
    Yunnie Cho: DO have relevant financial relationships ; Researcher:Mediwhale:Active (exists now) | Yong Yu Tan: DO NOT have relevant financial relationships | Tien Wong: DO have relevant financial relationships ; Consultant:Abbvie Pte Ltd:Past (completed) ; Other (please indicate in the box next to the company name):EyRIS (Co-founder):Active (exists now) ; Consultant:Shanghai Henlius:Active (exists now) ; Consultant:Sanofi:Past (completed) ; Consultant:Roche:Active (exists now) ; Consultant:Plano:Active (exists now) ; Consultant:Quaerite Biopharm Research Ltd:Active (exists now) ; Consultant:Opthea Limited:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Iveric Bio:Past (completed) ; Other (please indicate in the box next to the company name):VISRE (Co-founder):Active (exists now) ; Consultant:Carl Zeiss:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Aldropika Therapeutics :Active (exists now) | Ching-Yu Cheng: No Answer | Giuliano Generoso: DO NOT have relevant financial relationships | Ronaldo Correa Fabiano: DO NOT have relevant financial relationships | Isabela Bensenor: DO NOT have relevant financial relationships | Marcio Bittencourt: DO NOT have relevant financial relationships | Jun Hwan Cho: DO NOT have relevant financial relationships | Tyler Rim: DO have relevant financial relationships ; Employee:Mediwhale:Active (exists now) ; Individual Stocks/Stock Options:Mediwhale:Active (exists now) ; Ownership Interest:Mediwhale:Active (exists now) | Beom-Hee Choi: DO NOT have relevant financial relationships | Gyouchul Jung: No Answer | Chan Joo Lee: DO have relevant financial relationships ; Speaker:Norvatis:Past (completed) ; Individual Stocks/Stock Options:Mediwhale:Active (exists now) ; Speaker:Daiichi Sankyu:Past (completed) ; Speaker:Boryung Pharmaceutical:Past (completed) ; Speaker:Yuhan:Past (completed) ; Speaker:Hanmi Pharmaceutical:Past (completed) | Sung Ha Park: DO have relevant financial relationships ; Individual Stocks/Stock Options:Mediwhale:Active (exists now) ; Consultant:Skylab:Past (completed) ; Speaker:Donga:Past (completed) ; Speaker:Daewoong:Past (completed) ; Speaker:Viatris:Past (completed) ; Speaker:Organon:Past (completed) ; Research Funding (PI or named investigator):Sankyo:Active (exists now) ; Speaker:Boryung:Past (completed) | Hyeonmin Kim: No Answer | Chanyang Seo: No Answer | Sahil Thakur: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Calcium Clues: Decrypting the Coronary Artery Code

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts from these authors:
Prediction of Coronary Artery Calcium using Retinal Photographs via Deep Learning: Korean, Spanish and Indian populations

Tan Yong Yu, Masip David, Barriada Ruben, Servat Olga, Hernandez Cristina, Cheng Ching-yu, Savoy Florian, K R Nishanth, Rao Parthasarathy Divya, Bensenor Isabela, Wong Tien Yin, Correa Fabiano Ronaldo, Simo Rafael, Bittencourt Marcio, Generoso Giuliano, Cho Jun Hwan, Choi Beom-hee, Cho Yunnie, Thakur Sahil, Rim Tyler, Lee Chan Joo

Effect of Statin Therapy on Cardiovascular Events in High-Risk Group Identified by a Coronary Artery Calcium-Trained Deep Learning Model Using Retinal Imaging: A Propensity Score-Matched Study from the UK Biobank

Cho Yunnie, Cheng Ching Yu, Rim Tyler, Lee Chan Joo, Park Sung Ha, Kim Hyeonmin, Seo Chanyang, Yu Marco, Thakur Sahil, Wong Tien

You have to be authorized to contact abstract author. Please, Login
Not Available